KRONOS BIO

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. It develops therapies that modulate historically undruggable targets. The company leverages deep capabilities in high-throughput small-molecule microarrays (SMM), targeted protein degradation, and cancer biology in order to identify potent and selective compounds against transcription factors and other central drivers of oncogenic signaling.

#SimilarOrganizations #People #Financial #Event #Website #More

KRONOS BIO

Social Links:

Twitter

Industry:

Biotechnology Chemical Therapeutics

Founded:

2017-01-01

Address:

San Mateo, California, United States

Country:

United States

Website Url:

http://www.kronosbio.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

278 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins

Similar Organizations

1859-logo

1859

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

sunshine-biopharma-logo

Sunshine Biopharma

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.

Current Advisors List

jakob-loven_image

Jakob Loven Board of Directors @ Kronos Bio
Board_member

marianne-de-backer_image

Marianne De Backer Member Board of Directors @ Kronos Bio
Board_member
2021-01-01

Current Employees Featured

angela-koehler_image

Angela Koehler
Angela Koehler Scientific Founder @ Kronos Bio
Scientific Founder
2017-11-01

christopher-wilfong_image

Christopher Wilfong
Christopher Wilfong Chief Operating Officer and Co-Founder @ Kronos Bio
Chief Operating Officer and Co-Founder
2017-11-01

norbert-bischofberger_image

Norbert Bischofberger
Norbert Bischofberger President & Chief Executive Officer @ Kronos Bio
President & Chief Executive Officer
2018-08-01

jorge-dimartino_image

Jorge DiMartino
Jorge DiMartino Chief Medical Officer & Executive Vice President, Clinical Development @ Kronos Bio
Chief Medical Officer & Executive Vice President, Clinical Development
2019-12-01

douglas-c-saffran_image

Douglas C. Saffran
Douglas C. Saffran Vice President, Pharmacology @ Kronos Bio
Vice President, Pharmacology
2018-08-01

zung-to_image

Zung To
Zung To Hematology Franchise Leader, VP Development Operations, Portfolio Management, Biometrics & Quality @ Kronos Bio
Hematology Franchise Leader, VP Development Operations, Portfolio Management, Biometrics & Quality
2020-05-01

wes-trotter_image

Wes Trotter
Wes Trotter Vice President, Chemistry @ Kronos Bio
Vice President, Chemistry
2020-01-01

charles-lin_image

Charles Lin
Charles Lin Vice President, Biology @ Kronos Bio
Vice President, Biology
2019-12-01

christopher-lee_image

Christopher Lee
Christopher Lee Vice President, Program Management @ Kronos Bio
Vice President, Program Management

yasir-b-al-wakeel_image

Yasir B. Al-Wakeel
Yasir B. Al-Wakeel CFO & Head of Corporate Development @ Kronos Bio
CFO & Head of Corporate Development
2020-01-01

Founder

angela-koehler_image

Angela Koehler

christopher-wilfong_image

Christopher Wilfong

joshua-kazam_image

Joshua Kazam

Stock Details

Company's stock symbol is NASDAQ:KRON

Investors List

fidelity-management-and-research-company_image

Key Employee Changes

Date	New article
2022-02-01	Kronos Bio Announces Appointment of Elizabeth Olek as Senior Vice President of Clinical Development
2021-09-14	Kronos Bio Appoints Marni Kottle as Senior Vice President of Corporate Communications and Investor Relations
2020-08-19	Kronos Bio Names Yasir Al-Wakeel as Its First Chief Financial Officer
2020-07-20	Kronos Bio Appoints Barbara Kosacz, Chief Operating Officer and General Counsel
2020-06-16	Kronos Bio Appoints Christopher Dinsmore Chief Scientific Officer

Official Site Inspections

http://www.kronosbio.com Semrush global rank: 4.57 M Semrush visits lastest month: 2.27 K

Host Informations
Whois Informations

Loading ...